A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Article Published on 2023-01-312023-07-11 Journal: Cell Reports [Category] COVID19(2023년), [키워드] ACE2 receptor antigenic variation BA.2.75 COVID-19 CP: Immunology CP: Microbiology Immune escape RBD SARS-CoV-2 spike variant Variant of concern. [DOI] 10.1016/j.celrep.2022.111903 PMC 바로가기
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & JohnsonSARS-CoV-2 백신에 대한 포괄적인 검토: Pfizer, Moderna & Johnson & JohnsonReview Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Adenovirus administration age approval clinical clinical trial clinical trials coronavirus coronavirus. COVID-19 COVID-19 vaccine COVID-19 vaccines effective Efficacy General population group Johnson Johnson & Johnson Johnson & large cohort mechanism moderate Moderna mRNA vaccines Novel coronavirus ongoing trial ongoing trials outbreak pandemic participant Pfizer Safety SARS-CoV-2 SARS-CoV-2 coronavirus SARS-COV-2 infection shown Side effects Spike protein symptomatic SARS-CoV-2 infection tested the SARS-CoV-2 the spike protein the United State Trial United States Vaccinations Vaccine vaccine administration variant [DOI] 10.1080/21645515.2021.2002083 PMC 바로가기 [Article Type] Review
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy새로운 SARS-CoV-2 변종인 Omicron: 중증도 및 백신 효능에 대한 영향 평가Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Comment COVID-19 COVID-19 vaccine distribution Efficacy India Mild new SARS-CoV-2 omicron rising RT-PCR testing SARS-CoV-2 severity Vaccine vaccine candidate vaccine efficacy vaccine efficacy. Vaccine hesitancy variant variant of SARS-CoV-2 [DOI] 10.1080/21645515.2022.2034458 PMC 바로가기 [Article Type] Article
Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan일본 의료 센터에서 BNT162b2 mRNA COVID-19 백신의 효과 및 돌파구에 대한 실제 증거Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Asia Asian BNT162b2 BNT162b2 vaccine breakthrough COVID-19 vaccine delta variant demonstrated Effectiveness Effectiveness. Evidence evidence of hospital hygiene Infection infection control Japan measure mRNA of BNT162b2 Population populations Public hygiene Regulation required retrospective cohort study SARS-CoV-2 Spread Tokyo vaccination Vaccine variant while [DOI] 10.1080/21645515.2021.1984124 PMC 바로가기 [Article Type] Article
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective글로벌 관점에서 COVID-19 백신 부스터의 물류 판단Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] booster booster vaccination booster vaccinations COVID-19 COVID-19 vaccination COVID-19 vaccine Effectiveness equity Immune escape Immune-mediated immunocompromised individuals implementation indicate Perspective Premature protective immunity protocol response SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Side effects vaccination Vaccine Vaccine hesitancy vaccine. variant viral evolution waning immunity weighed [DOI] 10.1080/21645515.2021.2020572 PMC 바로가기 [Article Type] Article
Wastewater to clinical case (WC) ratio of COVID-19 identifies insufficient clinical testing, onset of new variants of concern and population immunity in urban communitiesArticle Published on 2022-12-202022-11-16 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, [키워드] allelic Alpha variant anticipated Canada clinical clinical testing Community complement COVID-19 COVID-19 pandemic decrease Delta VOC diagnostic Effectiveness effort eligibility Endemic epidemiological Epidemiology greater identify Immunity in-depth analysis increases in infection control investigated Metrics occurred omicron Pandemics population immunity proportion public health Public-health reduction reduction in reported required resulting SARS-CoV-2 Seven significant decrease significant increases in significantly Surveillance the disease the SARS-CoV-2 variant variants of concern VoC wastewater wastewater surveillance Wastewater-based epidemiology. [DOI] 10.1016/j.scitotenv.2022.158547 PMC 바로가기
Sewage surveillance of SARS-CoV-2 at student campus residences in the Western Cape, South AfricaArticle Published on 2022-12-102022-11-15 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] activity acute respiratory syndrome Cape collected coronavirus coronavirus disease country COVID-19 defined Delta diagnostic Efficacy Epidemiology evaluated genotyping Infection infections institution management monitoring Near-source WBE omicron outbreak Passive Passive sampling reported RT-qPCR SARS-CoV-2 sewage South Africa Stellenbosch Stellenbosch University student Student campus residences Surveillance Thermo Fisher variant wastewater Wastewater-based epidemiology. [DOI] 10.1016/j.scitotenv.2022.158028 PMC 바로가기
Impact of SARS-CoV-2 variants on mobility and air pollution in the United KingdomArticle Published on 2022-12-102022-11-16 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] activity affecting Algorithm Alpha baseline baseline level baseline levels contagiousness COVID-19 COVID-19 case death Delta event Government Immunity Impact Increases measure NO(2) normality Pollution prevalent Public public health reduced remained Result returned SARS-CoV-2 variant significant increase significantly social contact Spread Traffic Traffic. United Kingdom variant variants virus wildtype [DOI] 10.1016/j.scitotenv.2022.158279 PMC 바로가기
Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants코로나바이러스 질병 재조합 소단위 백신의 세 번째 용량으로 이종 부스팅은 다양한 중증 급성 호흡기 증후군 코로나바이러스 2 변이체에 대한 중화 항체 및 T 세포 면역을 증가시킵니다Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis Anti-RBD IgG anti-S booster vaccination CD4+ T cell components composite pattern coronavirus coronavirus disease COVID-19 COVID-19 vaccinations COVID-19 vaccine dose effective epitope Epitopes evaluated Evidence help Heterologous heterologous boosting homologous Humoral immunity Immune escape Immunity immunization strategy immunological in some inactivated Inactivated vaccine increase magnitude NAb NAbs natural infection Neutralizing Neutralizing antibodies neutralizing antibody neutralizing capacity omicron pandemic prime-boost strategy produced RBD IgG respiratory subunit Subunit vaccine Subunit vaccine. T cell T cell response T cells titre vaccination Vaccination strategies Vaccination strategy Vaccine Vaccine-induced immunity variant variants of concern waned [DOI] 10.1080/22221751.2022.2048969 PMC 바로가기 [Article Type] Article